This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates active inorganic growth and investment in the segment's market position.
The amount of goodwill recognized during the reporting period resulting from new business acquisitions integrated into t...
Standard acquisition-related disclosure found in segment-level financial reporting.
bsx_segment_specialty_pharmaceuticals_goodwill_acquired_during_period| FY'21 | |
|---|---|
| Value | $0.00 |